Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Geriatric Medicines Market Growth Performance Trended Historically, And What Lies Ahead?
The market size for geriatric medicines has seen a swift expansion in the past years. It is forecasted to surge from a value of $1227.91 billion in 2024 to $1427.01 billion in 2025, recording a compound annual growth rate (CAGR) of 16.2%. The factors contributing to this growth during the historic period include an increase in the incidence of strokes and chronic illnesses, a hike in the occurrence of cardiovascular diseases, amplified governmental aid, and an accentuated focus on tailor-made medicine.
Rapid expansion is anticipated in the geriatric medicines market size over the upcoming years. It is projected to reach $2578.21 billion in 2029, with a compound annual growth rate (CAGR) of 15.9%. This surge during the forecast period can largely be ascribed to the increasing incidences of health issues related to aging, growing geriatric populations, escalated healthcare spending, the advancement in geriatric medicine, and a rise in cases of hypertension. The period under forecast will also witness several trends like the employment of digital pills and wearable health tech, the creation of tools and strategies for managing multiple medications securely, breakthroughs in stem cell and gene therapy, wider adoption of telehealth platforms, and progress in early detection and prevention of diseases associated with aging.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20817&type=smp
Which Factors and External Forces Are Driving Demand in the Geriatric Medicines Market?
The geriatric medicines market is likely to see substantial growth due to the rising occurrence of health problems associated with aging. These health issues tend to escalate in severity and frequency as people get older, the result of which can be attributed to the aging process itself. Factors such as extended life spans, advancements in healthcare, and an elderly population have contributed to an increased incidence of these age-related health issues. Geriatric medicines offer specialized treatments for the elderly, thus enhancing their health outcomes and overall quality of life. In 2023, the UK’s Office for Health Improvement and Disparities (OHID) published a report that highlighted this trend. According to the report, in 2022, 17.6% of individuals aged 16 and above reported suffering from a long-lasting musculoskeletal (MSK) condition like arthritis or persistent back or joint problems, a rise from the 17.0% prevalence in 2021. Consequently, the increasing occurrence of health issues related to age is fueling the expansion of the geriatric medicines market.
Which Segments in the Geriatric Medicines Offer the Most Growth?
The geriatric medicinesmarket covered in this report is segmented –
1) By Therapeutics: Analgesics; Antihypertensive; Statins; Proton Pump Inhibitors; Anticoagulant; Antipsychotic; Other Therapeutics
2) By Condition: Cardiovascular; Arthritis; Neurological; Cancer; Osteoporosis; Respiratory; Other Conditions
3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
Subsegments:
1) By Analgesics: Non-Opioid Analgesics (Acetaminophen, NSAIDs); Opioid Analgesics (Morphine, Oxycodone); Topical Analgesics (Lidocaine Patches)
2) By Antihypertensive: Angiotensin-Converting Enzyme (ACE) Inhibitors; Angiotensin II Receptor Blockers (ARBs); Beta-Blockers; Calcium Channel Blockers; Diuretics; Alpha-Blockers
3) By Statins: Atorvastatin; Simvastatin; Rosuvastatin; Pravastatin; Lovastatin
4) By Proton Pump Inhibitors: Omeprazole; Esomeprazole; Lansoprazole; Pantoprazole; Rabeprazole
5) By Anticoagulant: Warfarin; Direct Oral Anticoagulants (DOACs): Dabigatran, Rivaroxaban, Apixaban; Heparin
6) By Antipsychotic: Atypical Antipsychotics; Typical Antipsychotics
7) By Other Therapeutics: Antidepressants (SSRIs, SNRIs); Antidiabetic Medications (Insulin, Metformin); Anticonvulsants; Anti-Inflammatory Drugs (Corticosteroids); Cognitive Enhancers (Donepezil, Memantine)
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=20817&type=smp
What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Geriatric Medicines Market?# Market?
North America was the largest region in the geriatric medicines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the geriatric medicines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Cutting-Edge Market Trends Are Expected to Drive theGeriatric Medicines Market’s Growth?
Leading firms in the geriatric medicines market are channeling their efforts towards the creation of innovative diabetes therapy, answering the increasing need for efficient solutions amongst the elderly. This new approach to diabetes therapy explores new-age treatments that excel beyond conventional methods, thereby enhancing treatment efficacy, safety, and patient results. For example, Akums Drugs & Pharmaceuticals Ltd., a pharmaceutical company based in India, launched an innovative combination therapy using Vildagliptin SR and Metformin SR in August 2023. This revolutionary formulation is designed specifically to manage Type 2 diabetes in elderly patients. Key benefits of this therapy include effective sugar level control and reduced risks of hypoglycemia and weight gain, which are crucial for this age group. By combining the effects of both drugs, the therapy increases insulin secretion and lowers blood sugar levels, therefore delivering safety and effectiveness. This product is approved by the Drug Controller General of India (DCGI).
View the full report here:
https://www.thebusinessresearchcompany.com/report/geriatric-medicines-global-market-report
What Are the Key Elements That Define the Geriatric Medicines Market?
Geriatric medicines are medications prescribed for individuals aged 65 and older, addressing the unique health needs of the elderly. They are designed to support cognitive function, mobility, and immune health while considering the physiological changes that affect drug metabolism in older adults. These medications manage chronic conditions and age-related symptoms, enhancing overall quality of life.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20817
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model